# Bone Scan Market

> Bone Scan Market Research Report Information: By Product (Radiopharmaceuticals, Imaging Devices), Application (Fractures, Arthritis, Paget's Disease of Bone, Cancer Originating in Bone), End User (Hospitals, Clinics, Diagnostic Centers) - Global Forecast till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.23%
- **2024:** $ 38.76 Billion
- **2025:** $ 40.79 Billion
- **2035:** $ 67.91 Billion
- **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Elekta AB (SE), Bracco Imaging S.p.A. (IT), Lantheus Medical Imaging, Inc. (US), Medtronic (US)

**Report ID:** MRFR/MED/3592-HCR · **Pages:** 110 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/bone-scan-market-5027

---

## Market Summary

## **Bone Scan Market Overview**

The Bone Scan Market Size was valued at USD 31.22 Billion in 2023. The Global Bone Scan industry is projected to grow from USD 38.76 Billion in 2024 to USD 45.11 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.23% during the forecast period (2024 - 2032). A bone scan is a test of nuclear medicine and is mostly used to diagnose various bone diseases such as arthritis and bone cancer. It includes an injection of radioactive material and then the bone scan. Radioactive material also known as the tracer is injected into a vein.

After injecting this material, the radiologist performs a bone scan. The radiologist may perform the bone scan in phases depending upon the condition to be diagnosed such as the presence of bone disease or cancer.

Rising prevalence of bone disease, increasing demand for imaging devices such as [MRI](../../../reports/magnetic-resonance-imaging-systems-market-6194), CT scan, SPECT scan, and increasing health care services are accelerating the growth of the market. Furthermore, the increasing expenditure on medical devices influences the market growth. Technological advancements in [radiology](../../../reports/radiology-services-market-7904) devices affecting the market growth. However, the efficiency of bone scan may hinder the market growth over the forecast period. Additionally, the bone scan may determine the inaccurate cause of the abnormality.

According to the WHO, about 59% of the mortality is due to chronic diseases and almost 35 million people die of chronic diseases across the globe.

###  **Intended Audience**

## **Key Players in the Bone Scan Market **

## **Segments **

The bone scan market is segmented on the basis of product, indication, device, and end user.

On the basis of the product, the market is segmented into radiopharmaceuticals and imaging devices. The imaging devices are further segmented into Magnetic Resonance Imaging (MRI), X-ray, Computed Tomography (CT), [Single-Photon Emission Computerized Tomography](../../../reports/single-photon-emission-computed-tomography-market-7231) (SPECT), and others.

On the basis of the application, the market is segmented into fractures, arthritis, Paget's disease of bone, cancer originating in bone, and others.

On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.

### **Regional Analysis of the Bone Scan Market      **

The Americas lead the bone scan market owing to the rising prevalence of bone disorders in the U.S. Furthermore, increasing demand for diagnostic services in various also influences the market growth. In North America, the U.S. is the largest market followed by Canada. Increasing penetration of orthopedic specialty hospitals and healthcare insurance is adding fuel to the market growth. Furthermore, the concentration of key players in the market along with the availability of various technologically advanced devices is boosting the market growth in the U.S.

Europe is the second largest bone scan market across the globe. The market is accelerated by the extensive use of diagnostic devices for diagnosis of various chronic diseases such as arthritis, diabetes, obesity and others. Furthermore, extensive research and development (R&D) activities carried out by clinical research and academic institutes stimulate the growth of the market. Germany and France contribute to the growth of the market owing to increasing expenditure on R&D and extensive demand for diagnostic devcies.

The Asia Pacific market is expected to grow at the fastest pace due to the high prevalence of chronic disease such as rheumatoid arthritis, osteoarthritis, obesity, diabetes, and other. Additionally, increasing number of bone injuries such as bone fractures boost the growth of the market.  To add further, increasing number of skilled professionals along with increasing awareness about the bone diseases and importance of imaging tests in the diagnosis of bone diseases, and injuries. In Asia Pacific, India and China are holding the largest market share followed by Japan.

Increasing expenditure on healthcare and improving healthcare infrastructure in various developing regions of Asia Pacific region are affecting the Bone Scan Market growth, positively.

The Middle East & Africa also show a steady rise in the Bone Scan Market owing to rising demand for diagnostic services and growing emphasis on diagnosis and treatment of bone disease. Developing healthcare infrastructure in the Middle East also fuels the growth of the market. In Africa, the market also shows a positive growth owing to the development of healthcare system in African countries and increasing demand for primary care services.

## Market Drivers

### Rising Geriatric Population

The Bone Scan Market is significantly influenced by the rising geriatric population, which is more susceptible to bone-related ailments. As life expectancy increases, the number of elderly individuals is projected to rise dramatically, leading to a higher prevalence of conditions such as osteoporosis and fractures. This demographic shift necessitates enhanced diagnostic tools, including bone scans, to effectively monitor and manage these conditions. The World Health Organization estimates that by 2050, the global population aged 60 years and older will reach 2 billion, underscoring the urgent need for effective healthcare solutions. Consequently, the demand for bone scans is likely to surge, driving growth in the Bone Scan Market as healthcare systems adapt to meet the needs of this expanding population.

### Focus on Preventive Healthcare

The Bone Scan Market is witnessing a shift towards preventive healthcare, which emphasizes early detection and management of bone-related conditions. This trend is driven by a growing recognition of the importance of maintaining bone health, particularly among aging populations. Preventive measures, including regular screenings and lifestyle modifications, are becoming more prevalent, leading to an increased utilization of bone scans. Healthcare providers are increasingly recommending bone density tests and scans as part of routine health assessments, which is likely to enhance patient outcomes. The emphasis on preventive care is expected to create new opportunities within the Bone Scan Market, as more individuals seek proactive measures to monitor their bone health and prevent potential complications.

### Technological Advancements in Imaging

The Bone Scan Market is experiencing a transformative phase due to rapid technological advancements in imaging techniques. Innovations such as hybrid imaging systems, which combine bone scans with other modalities like CT and MRI, enhance diagnostic accuracy and provide comprehensive insights into bone health. These advancements not only improve the detection of bone diseases but also facilitate better treatment planning. The integration of artificial intelligence in image analysis further streamlines the diagnostic process, potentially reducing the time required for interpretation. As a result, healthcare providers are increasingly adopting these advanced imaging technologies, which is likely to drive growth in the Bone Scan Market. The market is projected to expand significantly, with estimates suggesting a compound annual growth rate of over 5% in the coming years.

### Increasing Prevalence of Bone Disorders

The rising incidence of bone disorders, including osteoporosis and fractures, is a critical driver for the Bone Scan Market. As populations age, the prevalence of these conditions is expected to increase, leading to a higher demand for [diagnostic imaging](https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765) services. According to recent data, osteoporosis affects approximately 200 million individuals worldwide, highlighting the urgent need for effective screening and monitoring solutions. Bone scans play a pivotal role in diagnosing these disorders, allowing for early intervention and management. This growing patient population is likely to propel the demand for bone scans, thereby contributing to the overall expansion of the Bone Scan Market. Furthermore, increased awareness about bone health and preventive measures is expected to further stimulate market growth.

### Increased Investment in Healthcare Infrastructure

The Bone Scan Market is benefiting from increased investment in healthcare infrastructure, particularly in developing regions. Governments and private entities are recognizing the importance of advanced diagnostic tools in improving healthcare outcomes. Investments in hospitals and diagnostic centers are leading to the acquisition of state-of-the-art imaging equipment, including bone scan technology. This expansion of healthcare facilities is expected to enhance access to diagnostic services, thereby increasing the utilization of bone scans. Furthermore, as healthcare systems evolve, there is a growing emphasis on integrating advanced imaging modalities into routine practice. This trend is likely to bolster the Bone Scan Market, as improved infrastructure facilitates better patient care and encourages the adoption of innovative diagnostic solutions.

## Future Outlook

The Bone Scan Market is projected to grow at a 5.23% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of bone disorders, and rising healthcare expenditure.

**New opportunities:**

- Development of AI-driven imaging analysis tools
- Expansion of mobile bone scan units for remote diagnostics
- Partnerships with telemedicine platforms for enhanced patient access

By 2035, the Bone Scan Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product: Radiopharmaceuticals (Largest) vs. Imaging Devices (Fastest-Growing)

In the Bone Scan Market, the product segment comprises two main values: Radiopharmaceuticals and Imaging Devices. Radiopharmaceuticals hold the largest market share, primarily due to their pivotal role in facilitating accurate bone imaging. This segment remains crucial for patient diagnosis and management, making it the backbone of the market. While Imaging Devices, though currently smaller in share, are gaining traction due to technological advancements and increasing adoption in clinical settings, indicating a noteworthy shift towards more sophisticated imaging solutions.

Radiopharmaceuticals (Dominant) vs. Imaging Devices (Emerging)

Radiopharmaceuticals dominate the Bone Scan Market due to their essential role in diagnosing bone-related diseases. With their ability to target specific bone structures, they provide high-precision images that are critical for effective diagnosis and treatment planning. The growth in this segment is fueled by increased cancer cases and advancements in radio-pharmaceutical technology. In contrast, Imaging Devices represent an emerging segment that is evolving rapidly. The integration of advanced imaging technologies, such as PET and SPECT, enhances diagnostic accuracy and efficiency. Moreover, rising healthcare investments in diagnostic imaging equipment drive the adoption of these devices in hospitals and clinics.

### By Application: Fractures (Largest) vs. Cancer Originating in Bone (Fastest-Growing)

The Bone Scan Market is predominantly driven by the application of bone scans in the diagnosis of fractures, which holds the largest share within the market. Fractures account for a significant portion of the diagnostic procedures, as they are common injuries among various demographics, from athletes to the elderly. Following fractures, arthritic conditions and cancer originating in bone also represent important applications, although with comparatively smaller shares in the market. Additionally, Paget's Disease of Bone and others contribute to the diversified application landscape, appealing to specialized patient needs.

Fractures (Dominant) vs. Cancer Originating in Bone (Emerging)

Fractures are recognized as the dominant application in the Bone Scan Market due to their high prevalence across all age groups. The growth in sports injuries, along with an aging population, has significantly increased the demand for accurate fracture diagnosis and management through advanced imaging techniques. Conversely, cancer originating in bone is emerging as a fast-growing application due to the rising incidence of [bone cancers](https://www.marketresearchfuture.com/reports/bone-cancer-market-1922) and increased awareness regarding thorough diagnostic practices. As healthcare providers emphasize early intervention in cancer treatment, the use of bone scans is becoming critical, thus shaping a growing segment. This dynamic positions fracture diagnostics as well-established while [cancer diagnostics](https://www.marketresearchfuture.com/reports/cancer-diagnostics-market-1962) continues to expand rapidly.

### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

The Bone Scan Market shows a well-distributed market share across various end-user segments, with hospitals holding the largest portion due to their comprehensive imaging capabilities and access to technology. Clinics and diagnostic centers continue to grow in relevance, showing increasing shares as outpatient services expand and the need for rapid, accessible diagnostics rises. Meanwhile, other facilities contribute to the market, although to a lesser extent, focusing on specialized imaging services and targeted approaches to patient care.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals currently dominate the Bone Scan Market owing to their advanced imaging technologies and integrated care systems that support a wide range of diagnostic procedures. They offer a blend of medical expertise and sophisticated equipment, ensuring thorough assessments and immediate follow-ups. On the other hand, clinics are emerging as significant players by providing convenient and efficient services tailored toward outpatient needs. As patients seek more accessible healthcare options, clinics are expanding their offerings, including innovative scanning services and partnerships with diagnostic centers, positioning themselves as a critical alternative for bone scan imaging.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is the largest market for bone scans, accounting for approximately 45% of the global share. The region's growth is driven by increasing incidences of bone-related diseases, advancements in imaging technologies, and supportive regulatory frameworks. The demand for early diagnosis and treatment options is also rising, further propelling market growth. The U.S. is the primary contributor, followed by Canada, which holds around 15% of the market share.

The competitive landscape in North America is characterized by the presence of major players such as GE Healthcare, Siemens Healthineers, and Lantheus [Medical Imaging](https://www.marketresearchfuture.com/reports/medical-imaging-market-1995). These companies are continuously innovating and expanding their product offerings to meet the growing demand. The regulatory environment is favorable, with agencies like the FDA ensuring that new technologies are safe and effective, thus fostering market growth.

### Europe : Emerging Market with Potential

Europe is witnessing significant growth in the bone scan market, holding approximately 30% of the global share. The increasing prevalence of osteoporosis and other bone disorders, coupled with advancements in imaging technologies, are key drivers of this growth. Countries like Germany and the UK are leading the market, with Germany accounting for about 12% of the total share. Regulatory support for innovative diagnostic tools is also enhancing market dynamics.

The competitive landscape in Europe features key players such as Siemens Healthineers and Philips Healthcare, which are investing in research and development to enhance their product portfolios. The presence of a robust healthcare infrastructure and increasing healthcare expenditure further support market expansion. The European Medicines Agency plays a crucial role in regulating new imaging technologies, ensuring they meet safety and efficacy standards.

### Asia-Pacific : Rapidly Growing Market

Asia-Pacific is emerging as a significant player in the bone scan market, accounting for approximately 20% of the global share. The region's growth is fueled by rising healthcare investments, increasing awareness of bone health, and a growing elderly population. Countries like Japan and China are at the forefront, with Japan holding around 10% of the market share. Government initiatives aimed at improving healthcare access are also contributing to market expansion.

The competitive landscape in Asia-Pacific is evolving, with both local and international players vying for market share. Companies like Canon Medical Systems and Fujifilm Holdings are expanding their presence through strategic partnerships and technological advancements. The regulatory environment is becoming more structured, with agencies working to ensure that new imaging technologies meet necessary standards, thus fostering a conducive market environment.

### Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually developing its bone scan market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of diagnostic imaging, and a growing prevalence of bone diseases. Countries like South Africa and the UAE are leading the market, with South Africa accounting for approximately 3% of the total share. Government initiatives to enhance healthcare infrastructure are also playing a crucial role in market development.

The competitive landscape in this region is characterized by a mix of local and international players. Companies are focusing on expanding their product offerings and improving access to advanced imaging technologies. The regulatory environment is evolving, with efforts to establish standards for medical devices and imaging technologies, which will further support market growth in the coming years.

## Competitive Benchmarking

The Bone Scan Market is currently characterized by a dynamic competitive landscape, driven by advancements in imaging technologies and an increasing prevalence of bone-related diseases. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, each adopting distinct strategies to enhance their market positioning. GE Healthcare (US) focuses on innovation through the development of advanced imaging systems that integrate artificial intelligence, thereby improving diagnostic accuracy. Siemens Healthineers (DE) emphasizes partnerships with healthcare providers to expand its service offerings, while Philips Healthcare (NL) is investing in digital transformation initiatives to streamline operations and enhance patient care.

The competitive structure of the Bone Scan Market appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to respond swiftly to regional demands. This strategy not only reduces operational costs but also enhances responsiveness to market fluctuations. The collective influence of these key players shapes a competitive environment where innovation and operational efficiency are paramount.

In August 2025, Siemens Healthineers (DE) announced a strategic partnership with a leading healthcare provider to co-develop a new line of bone imaging solutions. This collaboration is expected to leverage Siemens' advanced imaging technology and the provider's clinical expertise, potentially leading to enhanced diagnostic capabilities and improved patient outcomes. Such partnerships may signify a shift towards collaborative innovation in the market.

In September 2025, GE Healthcare (US) launched a new AI-driven software platform designed to enhance the accuracy of bone scans. This platform integrates machine learning algorithms to assist radiologists in identifying abnormalities more effectively. The introduction of this technology underscores GE's commitment to innovation and positions the company as a leader in the integration of AI within imaging solutions.

In July 2025, Philips Healthcare (NL) expanded its operations in Asia by establishing a new manufacturing facility in India. This move is likely to enhance its production capabilities and reduce lead times for customers in the region. By localizing manufacturing, Philips aims to strengthen its supply chain and improve its competitive edge in the rapidly growing Asian market.

As of October 2025, the Bone Scan Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. These trends are reshaping competitive dynamics, with companies increasingly forming strategic alliances to enhance their technological capabilities and market reach. The focus appears to be shifting from price-based competition to differentiation through innovation and reliable supply chains. Looking ahead, it seems that companies that prioritize technological advancements and collaborative strategies will likely emerge as leaders in this evolving landscape.

## Report Scope

| MARKET SIZE 2024 | 38.76(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 40.79(USD Billion) |
| MARKET SIZE 2035 | 67.91(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.23% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Elekta AB (SE), Bracco Imaging S.p.A. (IT), Lantheus Medical Imaging, Inc. (US), Medtronic (US) |
| Segments Covered | Product |
| Key Market Opportunities | Integration of advanced imaging technologies enhances diagnostic accuracy in the Bone Scan Market. |
| Key Market Dynamics | Technological advancements in imaging techniques drive demand for bone scans, enhancing diagnostic accuracy and patient outcomes. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Bone Scan Market as of 2024?**
A: The Bone Scan Market was valued at 38.76 USD Billion in 2024.

**Q: What is the projected market valuation for the Bone Scan Market in 2035?**
A: The market is projected to reach 67.91 USD Billion by 2035.

**Q: What is the expected CAGR for the Bone Scan Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Bone Scan Market during 2025 - 2035 is 5.23%.

**Q: Which segments are included in the Bone Scan Market analysis?**
A: The market analysis includes segments such as Product, Application, and End User.

**Q: What are the projected revenues for the Radiopharmaceuticals segment by 2035?**
A: The Radiopharmaceuticals segment is projected to generate revenues between 20.0 and 35.0 USD Billion by 2035.

**Q: How much revenue is expected from the Imaging Devices segment by 2035?**
A: The Imaging Devices segment is anticipated to reach revenues of 18.76 to 32.91 USD Billion by 2035.

**Q: What applications are driving growth in the Bone Scan Market?**
A: Key applications include Fractures, Arthritis, Paget's Disease of Bone, and Cancer Originating in Bone.

**Q: What is the revenue forecast for the Arthritis application by 2035?**
A: The Arthritis application is expected to generate revenues between 10.0 and 18.0 USD Billion by 2035.

**Q: Which companies are considered key players in the Bone Scan Market?**
A: Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.

**Q: What is the expected revenue from hospitals as an end user by 2035?**
A: Hospitals are projected to generate revenues between 15.0 and 26.0 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/bone-scan-market-5027*